Endika Martin-Encinas - Publications

Affiliations: 
2015-2018 University of the Basque Country UPV/EHU 

16 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Martín-Encinas E, Lopez-Aguileta L, Palacios F, Alonso C. Aza-Povarov Reaction. A Method for the Synthesis of Fused Tetracyclic Chromeno[4,3-]pyrido[1,2-]pyrimidines. The Journal of Organic Chemistry. 89: 1099-1107. PMID 38177107 DOI: 10.1021/acs.joc.3c02220  0.777
2023 Melcón-Fernandez E, Martín-Encinas E, Palacios F, Galli G, Reguera RM, Martínez-Valladares M, Balaña-Fouce R, Alonso C, Pérez-Pertejo Y. Antileishmanial Effect of 1,5- and 1,8-Substituted Fused Naphthyridines. Molecules (Basel, Switzerland). 29. PMID 38202656 DOI: 10.3390/molecules29010074  0.783
2022 Perretti MD, Pérez-Pérez Y, Soler-Carracedo K, Martín-Encinas E, Alonso C, Scoccia J, Carrillo R. Hydrogen sulphide-triggered theranostic prodrugs based on the dynamic chemistry of tetrazines. Chemical Communications (Cambridge, England). PMID 35420098 DOI: 10.1039/d2cc01170k  0.727
2022 Martín-Encinas E, Selas A, Palacios F, Alonso C. The design and discovery of topoisomerase I inhibitors as anticancer therapies. Expert Opinion On Drug Discovery. 1-21. PMID 35321631 DOI: 10.1080/17460441.2022.2055545  0.782
2021 Rizo-Liendo A, Arberas-Jiménez I, Martin-Encinas E, Sifaoui I, Reyes-Batlle M, Chao-Pellicer J, Alonso C, Palacios F, Piñero JE, Lorenzo-Morales J. Naphthyridine Derivatives Induce Programmed Cell Death in . Pharmaceuticals (Basel, Switzerland). 14. PMID 34681237 DOI: 10.3390/ph14101013  0.761
2021 Jakobsen AK, Keller JG, Gonzalez M, Martin-Encinas E, Palacios F, Alonso C, Knudsen BR, Stougaard M. A Dual-Sensor-Based Screening System for In Vitro Selection of TDP1 Inhibitors. Sensors (Basel, Switzerland). 21. PMID 34300575 DOI: 10.3390/s21144832  0.756
2021 Martín-Encinas E, Rubiales G, Knudsen BR, Palacios F, Alonso C. Fused chromeno and quinolino[1,8]naphthyridines: Synthesis and biological evaluation as topoisomerase I inhibitors and antiproliferative agents. Bioorganic & Medicinal Chemistry. 40: 116177. PMID 33962152 DOI: 10.1016/j.bmc.2021.116177  0.806
2021 Selas A, Martin-Encinas E, Fuertes M, Masdeu C, Rubiales G, Palacios F, Alonso C. A patent review of topoisomerase I inhibitors (2016-present). Expert Opinion On Therapeutic Patents. PMID 33475439 DOI: 10.1080/13543776.2021.1879051  0.752
2020 Masdeu C, Fuertes M, Martin-Encinas E, Selas A, Rubiales G, Palacios F, Alonso C. Fused 1,5-Naphthyridines: Synthetic Tools and Applications. Molecules (Basel, Switzerland). 25. PMID 32752070 DOI: 10.3390/Molecules25153508  0.746
2020 Fuertes M, Masdeu C, Martin-Encinas E, Selas A, Rubiales G, Palacios F, Alonso C. Synthetic Strategies, Reactivity and Applications of 1,5-Naphthyridines. Molecules (Basel, Switzerland). 25. PMID 32708796 DOI: 10.3390/Molecules25143252  0.753
2020 Martín-Encinas E, Conejo-Rodríguez V, Miguel JA, Martínez-Ilarduya JM, Rubiales G, Knudsen BR, Palacios F, Alonso C. Novel phosphine sulphide gold(i) complexes: topoisomerase I inhibitors and antiproliferative agents. Dalton Transactions (Cambridge, England : 2003). 49: 7852-7861. PMID 32463416 DOI: 10.1039/D0Dt01467B  0.786
2020 Martín-Encinas E, Selas A, Tesauro C, Rubiales G, Knudsen BR, Palacios F, Alonso C. Synthesis of novel hybrid quinolino[4,3-b][1,5]naphthyridines and quinolino[4,3-b][1,5]naphthyridin-6(5H)-one derivatives and biological evaluation as topoisomerase I inhibitors and antiproliferatives. European Journal of Medicinal Chemistry. 195: 112292. PMID 32279049 DOI: 10.1016/J.Ejmech.2020.112292  0.747
2019 Martín-Encinas E, Rubiales G, Knudssen BR, Palacios F, Alonso C. Straightforward synthesis and biological evaluation as topoisomerase I inhibitors and antiproliferative agents of hybrid Chromeno[4,3-b][1,5]Naphthyridines and Chromeno[4,3-b][1,5]Naphthyridin-6-ones. European Journal of Medicinal Chemistry. 178: 752-766. PMID 31229877 DOI: 10.1016/J.Ejmech.2019.06.032  0.802
2019 Tejería A, Pérez-Pertejo Y, Reguera RM, Carbajo-Andrés R, Balaña-Fouce R, Alonso C, Martin-Encinas E, Selas A, Rubiales G, Palacios F. Antileishmanial activity of new hybrid tetrahydroquinoline and quinoline derivatives with phosphorus substituents. European Journal of Medicinal Chemistry. 162: 18-31. PMID 30408746 DOI: 10.1016/J.Ejmech.2018.10.065  0.792
2018 Maestro A, Martín-Encinas E, Alonso C, Martinez de Marigorta E, Rubiales G, Vicario J, Palacios F. Synthesis of novel antiproliferative hybrid bis-(3-indolyl)methane phosphonate derivatives. European Journal of Medicinal Chemistry. 158: 874-883. PMID 30253344 DOI: 10.1016/J.Ejmech.2018.09.011  0.753
2018 Alonso C, Fuertes M, Martín-Encinas E, Selas A, Rubiales G, Tesauro C, Knudssen BK, Palacios F. Novel topoisomerase I inhibitors. Syntheses and biological evaluation of phosphorus substituted quinoline derivates with antiproliferative activity. European Journal of Medicinal Chemistry. 149: 225-237. PMID 29501943 DOI: 10.1016/J.Ejmech.2018.02.058  0.772
Show low-probability matches.